Breaking News Instant updates and real-time market news.

OTIC

Otonomy

$1.87

0.05 (2.75%)

07:41
01/03/19
01/03
07:41
01/03/19
07:41

Otonomy sees sufficient funding through 2020

Otonomy expects that its current cash, cash equivalents, and short term investments will be sufficient to fund the company through completion of the OTIVIDEX Phase 3 trial, OTO-313 Phase 1/2 trial, and OTO-413 Phase 1/2 trial in 2020, and will support company operations into 2021.

OTIC Otonomy
$1.87

0.05 (2.75%)

11/15/18
CANT
11/15/18
INITIATION
Target $9
CANT
Overweight
Otonomy initiated with an Overweight at Cantor Fitzgerald
Cantor Fitzgerald analyst Charles Duncan last night initiated coverage of Otonomy with an Overweight rating and $9 price target. The analyst rolled out coverage on five Neuro-Innovator companies, focusing on "innovative technologies that can lead to breakthrough and disruptive treatments." He believes all five companies have "growth potential that exceeds current valuations, over time."
11/14/18
CANT
11/14/18
INITIATION
Target $9
CANT
Overweight
Otonomy initiated with an Overweight at Cantor Fitzgerald
Price target $9.
08/14/18
RHCO
08/14/18
NO CHANGE
Target $10
RHCO
Buy
Otonomy price target lowered to $10 from $15 at SunTrust
SunTrust analyst Edward Nash lowered his price on Otonomy to $10 and kept his Buy rating, saying that while he remains bullish on the company's position in the "under-addressed neuro-otology space" after its initiated Phase 3 trial for Otividex, he also sees a "lack of near term catalysts". The analyst adds that the next "significant" even will come from the Otividex results in the first half of 2020, but notes that the stock is currently trading "near cash".
03/19/18
JPMS
03/19/18
DOWNGRADE
JPMS
Underweight
Otonomy downgraded to Underweight from Neutral at JPMorgan
JPMorgan analyst Anupam Rama downgraded Otonomy to Underweight without a price target. The analyst sees "no true value drivers in 2018" with an additional third Phase 3 trial for Otividex in Meniere's disease needed for approval.

TODAY'S FREE FLY STORIES

APHA

Aphria

$4.97

0.46 (10.20%)

11:45
11/21/19
11/21
11:45
11/21/19
11:45
Options
Aphria call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BPTH

Bio-Path Holdings

$10.30

0.43 (4.36%)

11:44
11/21/19
11/21
11:44
11/21/19
11:44
Syndicate
Bio-Path Holdings announces $8M registered direct offering priced at-the-market »

Bio-Path Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

I

Intelsat

$6.63

-0.49 (-6.88%)

11:35
11/21/19
11/21
11:35
11/21/19
11:35
Options
Intelsat put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

11:35
11/21/19
11/21
11:35
11/21/19
11:35
General news
FX Action: USD-JPY bottomed »

FX Action: USD-JPY…

KLAC

KLA-Tencor

$163.03

-10.53 (-6.07%)

, LRCX

Lam Research

$264.95

-9.04 (-3.30%)

11:33
11/21/19
11/21
11:33
11/21/19
11:33
On The Fly
Semi equipment makers cut to sell among today's top calls »

Check out today's top…

KLAC

KLA-Tencor

$163.03

-10.53 (-6.07%)

LRCX

Lam Research

$264.95

-9.04 (-3.30%)

AMAT

Applied Materials

$57.58

-2.05 (-3.44%)

AMD

AMD

$39.89

-1.08 (-2.64%)

MGNX

MacroGenics

$8.00

-0.62 (-7.19%)

LOW

Lowe's

$117.68

-0.16 (-0.14%)

SPCE

Virgin Galactic

$9.25

0.14 (1.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 22

    Nov

  • 03

    Dec

  • 07

    Dec

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 10

    Dec

  • 12

    Dec

UBER

Uber

$29.44

1.42 (5.07%)

, ADYYF

Adyen

$0.00

(0.00%)

11:33
11/21/19
11/21
11:33
11/21/19
11:33
Periodicals
Uber 'not in conversations' with Germany's Wirecard, Reuters reports »

Uber denied a report in…

UBER

Uber

$29.44

1.42 (5.07%)

ADYYF

Adyen

$0.00

(0.00%)

WCAGY

Wirecard

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 04

    Dec

GPX

GP Strategies

$12.25

-0.14 (-1.13%)

11:31
11/21/19
11/21
11:31
11/21/19
11:31
Hot Stocks
GP Strategies holder Cove Street now 'active,' urges exploration of alternatives »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$198.26

0.76 (0.38%)

11:29
11/21/19
11/21
11:29
11/21/19
11:29
Periodicals
Facebook reviewing possible changes to political ad policy, WSJ says »

Facebook is weighing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

TWTR

Twitter

$30.40

1.23 (4.22%)

11:26
11/21/19
11/21
11:26
11/21/19
11:26
Hot Stocks
Twitter making hiding of replies available to all users globally »

In a blog post earlier,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

FB

Facebook

$198.58

1.08 (0.55%)

11:25
11/21/19
11/21
11:25
11/21/19
11:25
Periodicals
Breaking Periodicals news story on Facebook »

Facebook reviewing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

AXP

American Express

$119.14

-0.14 (-0.12%)

11:25
11/21/19
11/21
11:25
11/21/19
11:25
Options
American Express call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

LB

L Brands

$16.73

1.33 (8.64%)

11:21
11/21/19
11/21
11:21
11/21/19
11:21
Recommendations
L Brands analyst commentary  »

L Brands price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 05

    Dec

  • 27

    Feb

11:20
11/21/19
11/21
11:20
11/21/19
11:20
General news
Treasury announced a $113 B 3-pronged package of shorter/intermediate coupon offerings »

Treasury announced a $113…

AZN

AstraZeneca

$47.31

0.3 (0.64%)

11:17
11/21/19
11/21
11:17
11/21/19
11:17
Hot Stocks
FDA grants supplemental approval to AstraZeneca's Calquence »

As part of Project Orbis,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
11/21/19
11/21
11:17
11/21/19
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SITM

SiTime

$0.00

(0.00%)

11:16
11/21/19
11/21
11:16
11/21/19
11:16
Syndicate
Breaking Syndicate news story on SiTime »

SiTime opens at $16.90,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
11/21/19
11/21
11:16
11/21/19
11:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:15
11/21/19
11/21
11:15
11/21/19
11:15
General news
Breaking General news story  »

8-Week Bill Auction to be…

11:15
11/21/19
11/21
11:15
11/21/19
11:15
General news
Breaking General news story  »

4-Week Bill Auction to be…

11:15
11/21/19
11/21
11:15
11/21/19
11:15
General news
Breaking General news story  »

4-Week Bill Auction to be…

11:15
11/21/19
11/21
11:15
11/21/19
11:15
General news
Breaking General news story  »

8-Week Bill Auction to be…

LYFT

Lyft

$46.63

2.78 (6.34%)

11:10
11/21/19
11/21
11:10
11/21/19
11:10
Options
Heavy call volume in Lyft as shares lift 6% »

Heavy call volume in Lyft…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

11:09
11/21/19
11/21
11:09
11/21/19
11:09
General news
7-Yr Note Announcement CUSIP Number data reported »

7-Yr Note Announcement…

11:09
11/21/19
11/21
11:09
11/21/19
11:09
General news
7-Yr Note Announcement Offering Amount data reported »

7-Yr Note Announcement…

11:09
11/21/19
11/21
11:09
11/21/19
11:09
General news
5-Yr Note Announcement CUSIP Number data reported »

5-Yr Note Announcement…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.